What would it take to get peptides on the shelf?

An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply.

<img src='https://npr.brightspotcdn.com/dims3/default/strip/false/crop/4862x3158+0+0/resize/4862x3158!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F86%2F62%2F248c541e4b0d8c4604702187097a%2Fgettyimages-1213748565.jpg' alt='The popular and experimental drugs called peptides received unprecedented attention last month during a marathon hearing held by a panel that advises the Food and Drug Administration.'/><p>An FDA advisory panel recently voted to green-light some popular peptides. The decision brought enormous attention to the market for these products — and concerns about the unregulated supply. </p><p>(Image credit: Catherine Falls Commercial)</p><img src='https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=nx-s1-5913381' />